![[PDF] Le cannabis médical, déconfiné et déclassifié : retour sur le récent changement de classification internationale](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/08/psychotropes-28-1-couverture.png?resize=772%2C494&ssl=1)
[PDF] Le cannabis médical, déconfiné et déclassifié : retour sur le récent changement de classification internationale
Accès PDF pour l’article : Riboulet-Zemouli, Kenzi. Psychotropes, vol. 28, no. 1, 2022, pp. 71-104. DOI: 10.3917/psyt.281.0071
HIGH COMPLIANCE, a lex lata legalization for the non-medical cannabis industry
How to regulate recreational cannabis in accordance with the Single Convention on narcotic drugs, 1961.Paris and Washington, DC: FAAAT editions.![[PDF] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/03/DHS-paper-cover-KRZ-MK-2022.png?resize=682%2C503&ssl=1)
[PDF] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications
Full PDF access for the article as published in Drugs, Habits and Social Policy, 2022; 23(1): 5-21. DOI: 10.1108/DHS-11-2021-006
![[Journal’s page] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications](https://i0.wp.com/kenzi.zemou.li/wp-content/uploads/2022/03/Captura-de-Pantalla-2022-03-24-a-les-21.29.31.png?resize=367%2C248&ssl=1)
[Journal’s page] WHO’s first scientific review of medicinal Cannabis: from global struggle to patient implications
Access to Journal page for:Drugs, Habits and Social Policy, 2022; 23(1): 5-21. DOI: 10.1108/DHS-11-2021-006
‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology
Drug Science Policy and Law 6:1–37. DOI: 10.1177/2050324520945797